@article{ref1,
title="The pharmacogenomics of mood stabilizer response in bipolar disorder",
journal="Mental health clinician, The",
year="2012",
author="Leckband, S.G. and McCarthy, M. and Kelsoe, J.R.",
volume="1",
number="9",
pages="217-221",
abstract="Bipolar Disorder (BD) is a common psychiatric illness that has a recurring course and 17% - 24% lifetime prevalence of suicide attempts. Difficulty in diagnosis and individual variation in response point to a great need for personalized medicine. Studies to date have focused largely on lithium and suggest the idea that different medication responses may reflect different disease mechanisms. An overview of current pharmacogenomic studies will be presented and needs and future directions discussed. © 2012 by the authors.<p /><p>Language: en</p>",
language="en",
issn="2168-9709",
doi="10.9740/mhc.n99509",
url="http://dx.doi.org/10.9740/mhc.n99509"
}